What is Exagen Inc.'s revenue?

Exagen Inc. (XGN) generated $68.4M in revenue over the trailing twelve months, up 20.5% year over year.

Is Exagen Inc. profitable?

Exagen Inc. is not currently profitable: it reported a net loss of $20.2M over the trailing twelve months, a -29.5% net margin.

What are Exagen Inc.'s profit margins?

Gross margin is 58.3% and operating margin is -20.6%, with a -29.5% net margin.

What is Exagen Inc.'s earnings per share?

Exagen Inc.'s diluted EPS over the trailing twelve months is $-0.89.

Where does Exagen Inc.'s income statement data come from?

Every line is extracted from Exagen Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Exagen Inc. XGN Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Total revenue	$66.58M+19.7%	$55.64M+5.9%	$52.55M+15.3%	$45.56M-5.7%
Total cost of revenue	$27.78M+23.3%	$22.53M-2.4%	$23.09M-4.6%	$24.21M+17.6%
Gross profit	$38.8M+17.2%	$33.11M+12.4%	$29.46M+38.0%	$21.35M-23.0%
Gross margin	58.3%-1.2pp	59.5%+3.5pp	56.1%+9.2pp	46.9%-10.5pp
Research and development	$6.25M+16.4%	$5.38M+10.5%	$4.87M-50.7%	$9.88M+36.5%
Selling, general and administrative	$46.62M+12.7%	$41.37M-12.8%	$47.43M-8.8%	$52.02M+16.8%
Total costs & expenses	$52.87M+13.1%	$46.75M-17.2%	$56.47M-38.4%	$91.61M+26.6%
Operating income	-$14.07M-3.2%	-$13.64M+40.3%	-$22.84M+50.4%	-$46.05M-91.3%
Operating margin	-21.1%+3.4pp	-24.5%+19.0pp	-43.5%+57.6pp	-101.1%-51.2pp
Interest expense	$4.32M+93.3%	$2.23M-4.3%	$2.34M-4.6%	$2.45M-6.7%
Other income (expense), net	——	——	——	——
Income tax expense	$51K+325%	$12K-63.6%	$33K+112%	-$282K-261%
Net income	-$19.95M-32.0%	-$15.12M+36.2%	-$23.69M+50.0%	-$47.39M-76.5%
Net margin	-30%-2.8pp	-27.2%+17.9pp	-45.1%+58.9pp	-104%-48.4pp
Diluted earnings per share	-$0.92-10.8%	-$0.83+38.1%	-$1.34+51.4%	-$2.76-63.3%
Basic earnings per share	-$0.92-10.8%	-$0.83+38.1%	-$1.34+51.4%	-$2.76-63.3%
Weighted-average shares, diluted	84.1M+15.9%	72.6M+2.9%	70.6M+3.4%	68.2M+8.6%
Weighted-average shares, basic	84.1M+15.9%	72.6M+2.9%	70.6M+3.4%	68.2M+8.6%
Other income, net (Note 6)	——	——	——	——
Revenue From Contract With Customer Excluding Assessed Tax	$66.58M+19.7%	$55.64M+5.9%	$52.55M+15.3%	$45.56M-5.7%
EBIT	-$14.07M-3.2%	-$13.64M+40.3%	-$22.84M+50.4%	-$46.05M-91.3%
EBITDA	——	——	——	——
EBIT	-$14.07M-3.2%	-$13.64M+40.3%	-$22.84M+50.4%	-$46.05M-91.3%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Exagen Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Exagen Inc.'s revenue?: Exagen Inc. (XGN) generated $68.4M in revenue over the trailing twelve months, up 20.5% year over year.
Is Exagen Inc. profitable?: Exagen Inc. is not currently profitable: it reported a net loss of $20.2M over the trailing twelve months, a -29.5% net margin.
What are Exagen Inc.'s profit margins?: Gross margin is 58.3% and operating margin is -20.6%, with a -29.5% net margin.
What is Exagen Inc.'s earnings per share?: Exagen Inc.'s diluted EPS over the trailing twelve months is $-0.89.
Where does Exagen Inc.'s income statement data come from?: Every line is extracted from Exagen Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.